Peptide formulary
Tirzepatide
A dual GIP and GLP-1 receptor agonist prescribed as a compounded, physician-supervised weight-management protocol.
Coming soon
A full profile for Tirzepatide is on the way.
Tirzepatide is part of how Dr. Luria thinks about these goals. In the meantime, the deep-dive below covers its mechanism, evidence, and the patient profile it tends to fit.
This medication is a compounded prescription prepared by Blue Atlas Pharmacy, a licensed 503A compounding pharmacy, under the prescription of Dr. Jamie Luria, MD. Compounded medications are not FDA-approved for safety, efficacy, or quality.